Assessment and Diagnosis
22%of exam
Planning and Implementation
35%of exam
Evaluation and Modification
18%of exam
Patient and Community Education
25%of exam
Quick Facts
- Exam
- ANCC CV-BC
- Credential
- Cardiac-Vascular Nurse, Board Certified
- Questions
- 150 total; 125 scored
- Time
- 3 hours
- Pass
- 350 scaled of 500
- Pass rate
- 67% first-time (2025)
- Fee
- $395; $295 ANA member
- Valid
- 5 years
- Retest
- 60 days; 3 yearly
- Renewal
- 75 CE hours
- Blueprint
- Dec 5, 2024
Infarct Lead Groups
II, III, aVF = inferior = right coronary
STEMI vs NSTEMI
STEMI
- Complete occlusion
- Persistent ST elevation
- Immediate reperfusion
NSTEMI
- Partial occlusion
- ST depression or inversion
- Troponin positive
Elevation means immediate reperfusion
Chest Pain Triage
- New chest discomfort→12-lead within 10 minutes(First action)
- ST elevation present→Activate STEMI team(Start clock)
- Depression, troponin positive→NSTEMI pathway(Risk stratify)
- Normal ECG and troponin→Serial troponin, monitor(0/1-hour protocol)
- Inferior ST elevation→Add right-sided leads(Check V4R)
- Tearing pain, unequal pulses→Suspect aortic dissection(No fibrinolytics)
- Took PDE5 inhibitor→Withhold nitroglycerin(24 to 48 hours)
Hemodynamic Normals
- Cardiac output
- 4-8 L/min
- Cardiac index
- 2.5-4.0 L/min/m2Under 2.2 hypoperfusion
- CVP
- 2-8 mm HgRight preload
- PAOP / PCWP
- 6-12 mm HgOver 18 congestion
- PA pressure
- 15-30/8-15 mm Hg
- MAP
- 70-105 mm HgShock target 65
- SVR
- 800-1200 dynes-s/cm5
- Stroke volume index
- 33-47 mL/beat/m2
Acute Limb Ischemia
Pain, Pallor, Pulseless, Paresthesia, Paralysis, Poikilothermia
Stable vs Unstable Angina
Stable
- Predictable exertion trigger
- Relieved by rest
- Normal troponin
Unstable
- New or rest pain
- Not relieved by rest
- Normal troponin, still ACS
Pattern change means ACS
Infarct Leads
- V1-V2
- Septal; LAD
- V3-V4
- Anterior; LAD
- I, aVL, V5-V6
- Lateral; circumflex
- II, III, aVF
- Inferior; right coronary
- V7-V9
- Posterior; circumflex or RCA
- V4R
- Right ventricle; proximal RCAPreload dependent
- aVR elevation
- Left main or multivessel
Right vs Left Heart Failure
Right sided
- JVD, hepatomegaly
- Ascites, dependent edema
- Hepatojugular reflux
Left sided
- Crackles, orthopnea
- Exertional dyspnea
- Paroxysmal nocturnal dyspnea
Systemic vs pulmonary congestion
STEMI ECG Criteria
- Most leads
- 1 mm, two contiguous
- V2-V3, men 40+
- 2 mm elevation
- V2-V3, men under 40
- 2.5 mm elevation
- V2-V3, women
- 1.5 mm elevation
- Measured at
- J point
- Reciprocal change
- Depression in opposite wall
- New LBBB
- Not automatic STEMI; apply Sgarbossa
S3 vs S4
S3
- Early diastole
- Volume overload
- Decompensated heart failure
S4
- Late diastole
- Stiff ventricle
- Absent in atrial fibrillation
Volume vs stiffness
Heart Sounds
- S3
- Early diastole; volume overload
- S4
- Stiff ventricle; absent in AF
- Aortic stenosis
- Systolic; radiates to carotids
- Aortic regurgitation
- Diastolic; wide pulse pressure
- Mitral regurgitation
- Holosystolic; radiates to axilla
- Mitral stenosis
- Diastolic rumble; opening snap
- Mitral valve prolapse
- Mid-systolic click
- Pericardial rub
- Scratchy; better leaning forward
- Pulsus paradoxus
- Tamponade; drop over 10
Cardiac Labs
- hs-troponin
- Injury; needs rise or fall0/1-hour protocol
- BNP
- Wall stress; rules out HF
- NT-proBNP
- Usable on sacubitril/valsartan
- D-dimer
- Sensitive, not specific
- INR
- Warfarin effect
- aPTT
- Unfractionated heparin monitoring
- Anti-Xa
- Heparin or LMWH level
- Potassium
- MRA and ACE inhibitor safety
- Creatinine clearance
- DOAC dosing
ABI Values
- Calculation
- Ankle divided by brachial
- 1.00-1.40
- Normal
- 0.91-0.99
- Borderline
- 0.90 or less
- Peripheral artery disease
- 0.40 or less
- Severe ischemia; rest pain
- Above 1.40
- Noncompressible; use toe pressure
HFrEF Four Pillars
ARNI + beta-blocker + MRA + SGLT2 inhibitor
HFrEF vs HFpEF
HFrEF
- LVEF 40% or less
- Dilated, weak pump
- Four-pillar GDMT
HFpEF
- LVEF 50% or more
- Stiff, poor filling
- SGLT2i, diuretic, comorbidities
Weak pump vs stiff
STEMI Reperfusion Pathway
- At PCI-capable hospital→Primary PCI, 90 minutes
- Transfer under 120 minutes→Transfer for primary PCI
- PCI beyond 120 minutes→Fibrinolysis, 30 minutes
- Onset beyond 12 hours→PCI, not fibrinolysis
- Prior intracranial hemorrhage→Fibrinolysis contraindicated(Absolute)
- Cardiogenic shock→Immediate invasive strategy
- After reperfusion→DAPT, statin, beta-blocker
HFrEF Four Pillars
- ARNI
- Sacubitril/valsartan preferred
- Beta-blocker
- Carvedilol, metoprolol succinate, bisoprolol
- MRA
- Spironolactone or eplerenone
- SGLT2 inhibitor
- Dapagliflozin or empagliflozin
- Loop diuretic
- Congestion; no mortality benefit
- ARNI washout
- 36 hours off ACE inhibitor
- HFrEF
- LVEF 40% or less
- HFmrEF
- LVEF 41-49%
- HFpEF
- LVEF 50% or more
CHA2DS2-VASc Score
CHF, HTN, Age, Diabetes, Stroke, Vascular, Sex
Warfarin vs DOAC
Warfarin
- Routine INR monitoring
- Vitamin K interactions
- Vitamin K, 4F-PCC
DOAC
- No routine monitoring
- Renal and weight dosing
- Idarucizumab, andexanet alfa
Monitor INR vs renal dosing
Choosing HF GDMT
- LVEF 40% or less→Start four pillars
- Already on ACE inhibitor→Switch to ARNI(36-hour washout)
- ARNI not feasible→ACE inhibitor or ARB
- Potassium under 5.0→Add MRA(eGFR above 30)
- On other pillars→Add SGLT2 inhibitor(Diabetes not required)
- Volume overloaded→Add loop diuretic(Symptoms only)
- LVEF 35% after months→Refer for ICD(40 days post-MI)
- LBBB, QRS 150 ms→Add CRT
ACS Time Targets
- First ECG
- Within 10 minutes
- Primary PCI
- 90 minutes from contact
- Transfer for PCI
- 120 minutes from contact
- Fibrinolysis
- Door-to-needle 30 minutes
- Fibrinolysis window
- Within 12 hours onset
- Troponin protocol
- 0/1 or 0/2 hours
- Access preference
- Radial over femoral
- High-intensity statin
- Started during hospitalization
Cardioversion vs Defibrillation
Synchronized
- Pulse present
- AF, SVT, monomorphic VT
- Timed to R wave
Unsynchronized
- Pulseless patient
- VF, pulseless VT
- Polymorphic VT
Pulse means synchronize
AF Stroke Prevention
- New atrial fibrillation→Score CHA2DS2-VASc
- Score 2 men, 3 women→Anticoagulate(Risk 2% yearly)
- No mechanical valve→DOAC over warfarin
- Mechanical valve, rheumatic stenosis→Warfarin only
- AF beyond 48 hours→TEE or 3 weeks
- Unstable with rapid rate→Synchronized cardioversion
- Anticoagulation contraindicated→Consider appendage occlusion
Antithrombotics
- Aspirin
- Irreversible COX-1 blockade
- Clopidogrel
- P2Y12 prodrug; CYP2C19
- Ticagrelor
- Reversible P2Y12; dyspnea
- Prasugrel
- Avoid after stroke or TIA
- Unfractionated heparin
- aPTT titrated; reversible
- Enoxaparin
- Renally dosed LMWH
- Bivalirudin
- Direct thrombin inhibitor
- Argatroban
- Anticoagulant of choice, HIT
- DAPT duration
- At least 12 monthsTicagrelor alone after month
Radial vs Femoral Access
Radial
- Compression band
- Early ambulation
- Check hand perfusion
Femoral
- Supine bed rest
- Leg kept straight
- Watch retroperitoneal bleed
Radial bleeds less
Anticoagulation Targets
- AF or VTE
- INR 2.0-3.0
- Bioprosthetic valve
- INR 2.0-3.0
- Mechanical mitral valve
- INR 2.5-3.5
- Dabigatran reversal
- Idarucizumab
- Factor Xa reversal
- Andexanet alfa
- Warfarin reversal
- Vitamin K, 4F-PCC
- Heparin reversal
- Protamine sulfate
- DOAC monitoring
- Renal function, not INR
Procedures and Devices
- PCI
- Stent the culprit lesion
- CABG
- Bypass with graft conduits
- TAVR
- Transcatheter aortic valve replacement
- TEER
- Edge-to-edge mitral repair
- IABP
- Inflate diastole, deflate systole
- LVAD
- Continuous flow; Doppler MAP
- ECMO
- Temporary cardiopulmonary support
- ICD
- LVEF 35% or less40 days post-MI
- CRT
- LBBB with QRS 150 ms
- Severe aortic stenosis
- Mean gradient 40 mm Hg
- Severe mitral stenosis
- Valve area 1.5 cm2
Cath Access Care
- Radial access
- Band with patent hemostasis
- Radial checks
- Color, warmth, sensation, refill
- Femoral access
- Supine, leg straight, flat
- Hematoma
- Hold pressure; mark border
- Pseudoaneurysm
- Pulsatile mass; new bruit
- Retroperitoneal bleed
- Back or flank pain
- Contrast nephropathy
- Hydrate; trend creatinine
Tamponade Beck Triad
Hypotension + JVD + muffled heart sounds
Hypertensive Urgency vs Emergency
Urgency
- No target organ damage
- Oral agents
- Gradual outpatient lowering
Emergency
- Target organ damage
- IV titratable agent
- Lower 25% first hour
Organ damage decides
Hemodynamic Profiles
- Warm and dry→Compensated; continue GDMT
- Warm and wet→IV diuretic, vasodilator
- Cold and wet→Inotrope plus diuretic
- Cold and dry→Cautious fluid, then inotrope
- Index under 2.2, hypotensive→Cardiogenic shock pathway
- High CVP, clear lungs→Suspect right ventricular infarct
Drug Interactions
- Amiodarone + digoxin
- Halve the digoxin dose
- Amiodarone + warfarin
- INR climbs; reduce dose
- Nitrate + PDE5 inhibitor
- Profound refractory hypotension
- Sildenafil, vardenafil
- Hold nitrates 24 hours
- Tadalafil
- Hold nitrates 48 hours
- ACE inhibitor to ARNI
- 36-hour washout
- MRA + ACE inhibitor
- Hyperkalemia; recheck potassium
- Warfarin + vitamin K
- Consistency, not avoidance
- Statin + gemfibrozil
- Rhabdomyolysis risk
Adverse Events
- HIT
- Platelets fall 50%; thrombosisDay 5-10
- ACE inhibitor cough
- Switch to ARB
- ARNI angioedema
- Stop drug; secure airway
- Hyperkalemia
- Stop MRA above 5.5
- Digoxin toxicity
- Nausea, halos, arrhythmia
- Statin myopathy
- Muscle pain; check CK
- Amiodarone toxicity
- Thyroid, liver, lung, eye
- IV amiodarone
- In-line filter; central preferred
- Warfarin bleeding
- Hold; vitamin K
Emergency Thresholds
- Hypertensive emergency
- Lower 25% first hour
- Aortic dissection
- Systolic under 120 mm Hg
- Cardiogenic shock
- Systolic under 90; hypoperfusion
- Shock vasopressor
- Norepinephrine first line
- Stroke thrombolysis
- Within 4.5 hoursDoor-to-needle 60
- Thrombectomy window
- Up to 24 hours
- Post-arrest temperature
- 32-37.5 degrees CelsiusHold 36 hours
- Cardiac tamponade
- Beck triad; pulsus paradoxus
- High-risk PE
- Hypotension; consider thrombolysis
Smoking Cessation 5 A's
Ask, Advise, Assess, Assist, Arrange
ACC/AHA Stage vs NYHA Class
ACC/AHA stage
- Structural progression
- Stages A through D
- Never moves backward
NYHA class
- Functional symptoms
- Class I through IV
- Can improve or worsen
Structure vs symptoms
Education Barrier Picker
- Low health literacy→Teach-back, plain language
- Vision or dexterity limits→Pill organizer, large print
- Limited English proficiency→Qualified medical interpreter
- Cost barrier→Assistance program referral
- Recent MI or PCI→Refer cardiac rehabilitation
- Starting warfarin→Anticoagulation clinic referral
BP Categories
- Normal
- Under 120/80 mm Hg
- Elevated
- 120-129 systolic, under 80
- Stage 1
- 130-139 or 80-89
- Stage 2
- 140 or 90 higher
- Crisis
- Above 180/120 mm Hg
- Treatment goal
- Under 130/80 mm Hg
- Risk calculator
- PREVENT equations
Lifestyle Targets
- Aerobic activity
- 150 minutes weekly, moderate
- Vigorous activity
- 75 minutes weekly
- Strength training
- Two or more days
- Sodium limit
- Under 2,300 mg dailyOptimal 1,500 mg
- High-intensity statin
- Lowers LDL 50% or more
- Post-ACS LDL
- Add nonstatin at 70
- Smoking cessation
- Counseling plus pharmacotherapy
- Nonmodifiable risks
- Age, sex, race, family
Home Monitoring
- Daily weight
- Same scale, after voiding
- Report weight gain
- 2-3 pounds overnight, 5 weekly
- BP technique
- Rest 5 minutes, bare arm
- BP readings
- Two, one minute apart
- Nitroglycerin rule
- No relief 5 minutes, 911
- Symptom action plan
- Green, yellow, red zones
- Teach-back
- Patient explains in own words
Community Resources
- Cardiac rehab
- Up to 36 supervised sessions
- Rehab referral
- MI, PCI, CABG, valve
- HF rehab coverage
- LVEF 35% or less
- Anticoagulation clinic
- Dosing; time in range
- Home INR testing
- Fingerstick point-of-care meter
- Remote CIED check
- Lead, battery, fluid trends
- HF follow-up
- Visit within 7 days
Common Traps
Injury vs infarction
Troponin shows injury ≠ MI needs ischemic evidence
S3 vs S4
S3 is volume ≠ S4 is stiffness
Urgency vs emergency
Urgency spares organs ≠ Emergency damages organs
Sync vs defibrillate
Pulse means synchronize ≠ Pulseless means defibrillate
Rate vs rhythm control
Rate slows ventricles ≠ Rhythm restores sinus
Nitrates in RV infarct
RV is preload dependent ≠ Nitrates drop pressure abruptly
Vitamin K teaching
Consistency, not avoidance ≠ Report every diet change
BNP on ARNI
Sacubitril raises BNP ≠ NT-proBNP stays usable
Stage vs class
HF stage never reverses ≠ NYHA class can improve
Scored vs pretest
125 questions scored ≠ 25 pretest not scored
Last Minute
- 1.Planning 35% is largest domain
- 2.Education 25%; Assessment 22%
- 3.Evaluation and Modification is 18%
- 4.150 questions; only 125 scored
- 5.Pass = 350 scaled of 500
- 6.Primary PCI within 90 minutes
- 7.Fibrinolysis needle within 30 minutes
- 8.HFrEF pillars: ARNI, BB, MRA, SGLT2i
- 9.ACE to ARNI = 36-hour washout
- 10.Anticoagulate CHA2DS2-VASc 2 men, 3 women
- 11.INR 2-3; mechanical mitral 2.5-3.5
- 12.ABI 0.90 or less = PAD
- 13.BP treatment goal under 130/80
- 14.Report 2-3 pound overnight gain
- 15.Nitroglycerin: no relief 5 minutes, 911
- 16.Cardiac rehab: up to 36 sessions
- 17.Pulse = synchronize; pulseless = defibrillate
- 18.Hold nitrates after PDE5 inhibitors
Explore More ANCC Nursing Certifications
Continue into nearby exams from the same family. Each card keeps practice questions, study guides, flashcards, videos, and articles in one place.
More From This Family
Videos and articles for deeper review.
